Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Yale Cancer Center ×

Yale Cancer Center

This institution is selected. Its supporting articles are shown below.

Yale Cancer Center1

Articles mentioning Yale Cancer Center

1 articles · page 1 of 1

1345 Initial phase 1a/1b results of STK-012, an α/β IL-2 receptor biased partial agonist, with pembrolizumab, pemetrexed, and carboplatin in 1L PD-L1 negative non-squamous NSCLC

jitc · abstract · 2025-11-07 · 1 matching annotations

80.3%

Dana Farber Cancer Institute Memorial Sloan Kettering Cancer Center Yale Cancer Center The James Cancer Center Georgetown Lombardi Cancer Center Hoag Family Cancer Institute NYU Grossman School of Medicine STK-012 1L NSQ NSCLC pembrolizumab

…CT The James Cancer Center, Ohio State University, Columbus, OH Dana Farber Cancer Institute, Boston, MA, Columbia University Irving Medical Center, New Yor…

Browse institutions

Yale Cancer Center

Articles mentioning Yale Cancer Center

1345 Initial phase 1a/1b results of STK-012, an α/β IL-2 receptor biased partial agonist, with pembrolizumab, pemetrexed, and carboplatin in 1L PD-L1 negative non-squamous NSCLC